. Correction to Brigatinib in Japanese patients with ALK-positive non-small-cell lung cancer: Final results of the phase 2 J-ALTA trial.Cancer science. 2023, 114 (12): 4776-4777
Hiroshi Tsuge, Daisuke Kawakita, Yukari Taniyama, Isao Oze, Yuriko N Koyanagi, Megumi Hori, Kayo Nakata, Hiromi Sugiyama, Isao Miyashiro, Izumi Oki, Yoshikazu Nishino, Kota Katanoda, Yuri Ito, Akiko Shibata, Tomohiro Matsuda, Shinichi Iwasaki, Keitaro Matsuo, Hidemi Ito. Subsite-specific trends in mid- and long-term survival for head and neck cancer patients in Japan: A population-based study.Cancer science. 2023, :
Yefei Zhang, Jiahui Chen, Jia Tian, Yehui Zhou, Yan Liu. Role and function of plakophilin 3 in cancer progression and skin disease.Cancer science. 2023, :